Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Food on the Pharmacokinetics of ABT-072

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

January 31, 2010

Conditions
Hepatitis C
Interventions
DRUG

ABT-072

See Arms information for a detailed description.

DRUG

Placebo

See Arms information for a detailed description.

Trial Locations (1)

60085

Site Reference ID/Investigator# 23742, Waukegan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY